Schatzberg A F, Samson J A, Bloomingdale K L, Orsulak P J, Gerson B, Kizuka P P, Cole J O, Schildkraut J J
Affective Disease Program, McLean Hospital, Belmont, Mass.
Arch Gen Psychiatry. 1989 Mar;46(3):260-8. doi: 10.1001/archpsyc.1989.01810030066009.
Data on 24-hour urinary levels of catecholamines and metabolites were determined in 114 depressed patients. For each patient, a D-type score was calculated, using a discriminant function equation that was previously derived using data from an independent group of depressed patients. Of all measures, D-type scores provided the highest sensitivity and specificity for separating bipolar/schizoaffective-depressed patients from all remaining patients or from those patients with unipolar nonendogenous depressions. Using Research Diagnostic Criteria (RDC), bipolar I patients demonstrated significantly lower D-type scores than did all other RDC depressive subtypes, including bipolar II disorders. Similar findings were observed using the Clinical Inventory for the Diagnosis and Classification of Affective Disorders (CIDCAD) system: bipolar/schizoaffective patients demonstrated significantly lower D-type scores than all remaining subtypes, including diagnostically unclassifiable, probable bipolar patients (a category somewhat akin to RDC bipolar II disorder). Data pointed to the heterogeneity of bipolar disorders. Catecholamine and metabolite data in this study were compared with recent studies of others.
对114名抑郁症患者测定了24小时尿儿茶酚胺及其代谢产物水平。为每位患者计算了D型评分,使用的判别函数方程是先前利用一组独立抑郁症患者的数据推导出来的。在所有测量指标中,D型评分在区分双相/分裂情感性抑郁症患者与其他所有患者或单相非内源性抑郁症患者时,具有最高的敏感性和特异性。采用研究诊断标准(RDC),双相I型患者的D型评分显著低于所有其他RDC抑郁亚型,包括双相II型障碍。使用情感障碍诊断与分类临床量表(CIDCAD)系统也观察到了类似的结果:双相/分裂情感性患者的D型评分显著低于所有其他亚型,包括诊断上无法分类的、可能的双相患者(这一类别有点类似于RDC双相II型障碍)。数据表明双相情感障碍具有异质性。本研究中的儿茶酚胺和代谢产物数据与其他近期研究进行了比较。